Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 208
Filtrer
3.
JAMA ; 2024 Jun 20.
Article de Anglais | MEDLINE | ID: mdl-38900490

RÉSUMÉ

Importance: Sudden death and cardiac arrest frequently occur without explanation, even after a thorough clinical evaluation. Calcium release deficiency syndrome (CRDS), a life-threatening genetic arrhythmia syndrome, is undetectable with standard testing and leads to unexplained cardiac arrest. Objective: To explore the cardiac repolarization response on an electrocardiogram after brief tachycardia and a pause as a clinical diagnostic test for CRDS. Design, Setting, and Participants: An international, multicenter, case-control study including individual cases of CRDS, 3 patient control groups (individuals with suspected supraventricular tachycardia; survivors of unexplained cardiac arrest [UCA]; and individuals with genotype-positive catecholaminergic polymorphic ventricular tachycardia [CPVT]), and genetic mouse models (CRDS, wild type, and CPVT were used to define the cellular mechanism) conducted at 10 centers in 7 countries. Patient tracings were recorded between June 2005 and December 2023, and the analyses were performed from April 2023 to December 2023. Intervention: Brief tachycardia and a subsequent pause (either spontaneous or mediated through cardiac pacing). Main Outcomes and Measures: Change in QT interval and change in T-wave amplitude (defined as the difference between their absolute values on the postpause sinus beat and the last beat prior to tachycardia). Results: Among 10 case patients with CRDS, 45 control patients with suspected supraventricular tachycardia, 10 control patients who experienced UCA, and 3 control patients with genotype-positive CPVT, the median change in T-wave amplitude on the postpause sinus beat (after brief ventricular tachycardia at ≥150 beats/min) was higher in patients with CRDS (P < .001). The smallest change in T-wave amplitude was 0.250 mV for a CRDS case patient compared with the largest change in T-wave amplitude of 0.160 mV for a control patient, indicating 100% discrimination. Although the median change in QT interval was longer in CRDS cases (P = .002), an overlap between the cases and controls was present. The genetic mouse models recapitulated the findings observed in humans and suggested the repolarization response was secondary to a pathologically large systolic release of calcium from the sarcoplasmic reticulum. Conclusions and Relevance: There is a unique repolarization response on an electrocardiogram after provocation with brief tachycardia and a subsequent pause in CRDS cases and mouse models, which is absent from the controls. If these findings are confirmed in larger studies, this easy to perform maneuver may serve as an effective clinical diagnostic test for CRDS and become an important part of the evaluation of cardiac arrest.

5.
Heart Rhythm ; 21(5): 519-520, 2024 May.
Article de Anglais | MEDLINE | ID: mdl-38692816
8.
JAMA Intern Med ; 184(3): 326-327, 2024 Mar 01.
Article de Anglais | MEDLINE | ID: mdl-38315468

RÉSUMÉ

This case report describes a patient in their 70s with hypertension and heart failure presenting to the emergency department with chest discomfort, nausea, anorexia, and weakness.


Sujet(s)
Digoxine , Défaillance cardiaque , Humains , Digoxine/effets indésirables , Cardiotoniques/effets indésirables , Défaillance cardiaque/induit chimiquement , Défaillance cardiaque/traitement médicamenteux
9.
J Electrocardiol ; 83: 26-29, 2024.
Article de Anglais | MEDLINE | ID: mdl-38295539

RÉSUMÉ

BACKGROUND: Alcohol consumption is associated with a higher increased risk of atrial fibrillation (AF), but the acute effects on cardiac electrophysiology in humans remain poorly understood. The HOw ALcohol InDuces Atrial TachYarrhythmias (HOLIDAY) Trial revealed that alcohol shortened pulmonary vein atrial effective refractory periods, but more global electrophysiologic changes gleaned from the surface ECG have not yet been reported. METHODS: This was a secondary analysis of the HOLIDAY Trial. During AF ablation procedures, 100 adults were randomized to intravenous alcohol titrated to 0.08% blood alcohol concentration versus a volume and osmolarity-matched, masked, placebo. Intervals measured from 12­lead ECGs were compared between pre infusion and at infusion steady state (20 min). RESULTS: The average age was 60 years and 11% were female. No significant differences in the P-wave duration, PR, QRS or QT intervals, were present between alcohol and placebo arms. However, infusion of alcohol was associated with a statistically significant relative shortening of the JT interval (r: -14.73, p = 0.048) after multivariable adjustment. CONCLUSION: Acute exposure to alcohol was associated with a relative reduction in the JT interval, reflecting shortening of ventricular repolarization. These acute changes may reflect a more global shortening of refractoriness, suggesting immediate proarrhythmic effects pertinent to the atria and ventricles.


Sujet(s)
Fibrillation auriculaire , Électrocardiographie , Adulte , Femelle , Humains , Mâle , Adulte d'âge moyen , Alcoolémie , Atrium du coeur , Essais contrôlés randomisés comme sujet
12.
Circ Arrhythm Electrophysiol ; 17(1): e012072, 2024 01.
Article de Anglais | MEDLINE | ID: mdl-38099441

RÉSUMÉ

Although there is consensus on the management of patients with Brugada Syndrome with high risk for sudden cardiac arrest, asymptomatic or intermediate-risk patients present clinical management challenges. This document explores the management opinions of experts throughout the world for patients with Brugada Syndrome who do not fit guideline recommendations. Four real-world clinical scenarios were presented with commentary from small expert groups for each case. All authors voted on case-specific questions to evaluate the level of consensus among the entire group in nuanced diagnostic and management decisions relevant to each case. Points of agreement, points of controversy, and gaps in knowledge are highlighted.


Sujet(s)
Syndrome de Brugada , Arrêt cardiaque , Humains , Syndrome de Brugada/diagnostic , Syndrome de Brugada/thérapie , Électrocardiographie , Arrêt cardiaque/diagnostic , Arrêt cardiaque/thérapie , Mort subite cardiaque/étiologie , Mort subite cardiaque/prévention et contrôle , Consensus
13.
Circulation ; 148(23): 1907-1910, 2023 12 05.
Article de Anglais | MEDLINE | ID: mdl-38048393
14.
16.
19.
Heart Rhythm ; 20(10): 1414-1415, 2023 Oct.
Article de Anglais | MEDLINE | ID: mdl-37777302
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...